UPDF AI

Seasonal influenza vaccines.

A. Fiore,C. Bridges,N. Cox

2009 · DOI: 10.1007/978-3-540-92165-3_3
Current Topics in Microbiology and Immunology · 247 Citations

TLDR

Study of the safety of LAIV among young children suggest an increased risk of wheezing in some young children, and the vaccine is not recommended for children younger than 2 years old, ages 2-4 old with a history of recurrent wheazing or reactive airways disease, or older persons who have any medical condition that confers an increasedrisk of influenza-related complications.